Damage to myelin, the protective sheath surrounding nerve fibers, impairs the brain's ability to transmit signals efficiently ...

There has been some incredible research into the role this DNA plays in modern human neurodevelopment, so here's an overview ...

Many of the estimated 1 million people in the U.S. with multiple sclerosis deal with eye and vision problems, as well as ...

Baron Discovery Fund highlighted stocks like Axon Enterprise, Inc. (NASDAQ:AXON), in the fourth quarter 2024 investor letter. Axon Enterprise, Inc. (NASDAQ:AXON) manufacturers conducted energy ...

We further verified through experiments that M-Ang2-EVs can promote microglia/macrophages to phagocytose sphingomyelin, promote axon remyelination and axon ... M-Ang2-EVs enhance microglial ...

Demyelination in MS occurs when the immune system attacks and damages the myelin sheaths that insulate and nourish axons and nerve fibers in the central nervous system, leading to multifocal ...

Discover how the new Axon SkySwap Program can help your agency transition to NDAA-compliant, American-made and autonomous drone solutions. This initiative offers discounts on secure hardware, software ...

The current human tissue-based study provides convincing evidence correlating hippocampal expressions of RNA guanine-rich G-quadruplexes with aging and with Alzheimer's Disease presence and severity.

Patient enrollment has been completed ahead of schedule in a Phase 2 clinical trial evaluating Contineum Therapeutics‘ PIPE-307, an oral therapy aiming to restore myelin — a process known as ...

Image source: Axon. What to expect for Axon in 2025 Axon's valuation could put pressure on the stock this year because it currently trades at a price-to-earnings ratio of 150 and a price-to-sales ...

Axon wrapped up what should be its 13th consecutive year of top-line growth north of 19%. The stock was a big gainer during the last January when a new president was inaugurated. Axon isn't cheap ...